Direct comparison two fixed-ratio combination glucagon-like peptide receptor agonist and basal insulin on glycemic and non glycemic parameters in type 2 diabetes

BACKGROUND: Two types of fixed-ratio combinations of basal insulin and a glucagon-like peptide-1 receptor agonist (GLP-1RA) have been approved for use in type 2 diabetes. One is insulin degludec/liraglutide (iDergLira), and the other is insulin glargine/lixisenatide (iGlarLixi). Direct comparisons b...

Descripción completa

Detalles Bibliográficos
Autores principales: Risovic, Ivona, Dumanovic, Mirjana Sumarac, Bojic, Mirjana, Djekic, Danijel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9890870/
https://www.ncbi.nlm.nih.gov/pubmed/36726134
http://dx.doi.org/10.1186/s12902-023-01282-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9890870/
https://www.ncbi.nlm.nih.gov/pubmed/36726134
http://dx.doi.org/10.1186/s12902-023-01282-w

Ejemplares similares